Editor's Note For diabetic patients with obesity and chronic kidney disease (CKD), metabolic bariatric surgery could protect the kidneys better than therapy with glucagon-like peptide-1 receptor agonists (GLP-1RA), according to research published in the September issue of the Annals of Surgery. Conducted at a large US health system, the study…
Editor's Note Lumbar spinal fusion procedures are significantly more likely to fail in individuals with diabetes, according researchers at The University of Toledo. According to a July 9 EurekAlert! report on the study, published in JBMR Plus, diabetic patients are already known to have a higher risk of infection from…
Editor's Note Intraoperative infusion of dexmedetomidine (DEX) could help improve glycemic control and reduce insulin requirements in diabetic patients undergoing cardiac surgery, according to a July 25 article in Medical Dialogues. The article focuses on a prospective observational study published in the journal Annals of Cardiac Anesthesia. The study included…
Editor's Note Roux-en-Y gastric bypass surgery kept type 2 diabetes in remission for up to 15 years and maintained most of the weight loss for up to 20 years in a long-term study, according to a June 12 report in SciTech Daily. Presented the same day at The American Society…
Editor's Note Bariatric surgery provides longer-lasting, more effective weight loss than GLP-1 receptor agonists and lifestyle interventions, according to systematic reviews of medical literature from 2020 to 2024. Medical Xpress reported the news June 11. Presented at the American Society for Metabolic and Bariatric Surgery (ASMBS) 2024 Annual Scientific Meeting,…
Editor's Note Two new studies show robotic surgery outperforming laparoscopic approaches to metabolic and bariatric procedures in terms of operating times, length of hospital stay, and complication rates, according to a June 11 report in Medical Xpress. Both studies were presented at the American Society for Metabolic and Bariatric Surgery…
Editor's Note Preoperative use of GLP-1 receptor agonists (RA) medications such as Ozempic and Wegovy is safe, according to a study published in the June issue of the American Journal of Gastroenterology. Controversy has swirled around these drugs due to the risk of slowed stomach emptying increasing a patient’s odds…
Editor's Note Researchers claim a stem cell transplant cured type 2 diabetes in a 59-year-old man who previously needed multiple daily insulin injections, the South China Morning Post reported May 27. The Chinese researchers behind the reported breakthrough published details of the case April 30 in the journal Cell Discovery.…
Editor's Note A study published May 7 in JAMA Open found no significant risk of periprosthetic joint infection (PJI) when colonoscopy is performed within one year of total joint arthroplasty (TJA), whether the colonoscopy was done before or after the surgery. However, certain comorbidities such as kidney and pulmonary disease,…
Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…